Michael E. Merhige

2.1k total citations
34 papers, 1.0k citations indexed

About

Michael E. Merhige is a scholar working on Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Michael E. Merhige has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Biomedical Engineering. Recurrent topics in Michael E. Merhige's work include Cardiac Imaging and Diagnostics (26 papers), Advanced MRI Techniques and Applications (16 papers) and Advanced X-ray and CT Imaging (9 papers). Michael E. Merhige is often cited by papers focused on Cardiac Imaging and Diagnostics (26 papers), Advanced MRI Techniques and Applications (16 papers) and Advanced X-ray and CT Imaging (9 papers). Michael E. Merhige collaborates with scholars based in United States and Canada. Michael E. Merhige's co-authors include Brent A. Williams, K. Lance Gould, Richard W. Smalling, Richard A. Goldstein, A. Nishikawa, Linda L. Demer, Nizar A. Mullani, Richard L. Kirkeeide, Sharmila Dorbala and Benjamin J.W. Chow and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Michael E. Merhige

33 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Merhige United States	14	709	396	193	176	101	34	1.0k
Jessica Zhou United States	14	158 0.2×	38 0.1×	230 1.2×	42 0.2×	27 0.3×	23	682
Shung‐Shung Sun Taiwan	13	183 0.3×	26 0.1×	118 0.6×	12 0.1×	74 0.7×	62	539
Andrew L. Kaplan United States	12	45 0.1×	82 0.2×	99 0.5×	19 0.1×	63 0.6×	18	361
Nicolas Giraud France	6	97 0.1×	72 0.2×	82 0.4×	35 0.2×	26 0.3×	17	495
Ragnhild Helseth Norway	13	52 0.1×	84 0.2×	69 0.4×	15 0.1×	45 0.4×	36	558
Roka Namoto Matsubayashi Japan	10	185 0.3×	12 0.0×	111 0.6×	27 0.2×	31 0.3×	16	402
Vyron Markussis Greece	10	87 0.1×	234 0.6×	39 0.2×	9 0.1×	13 0.1×	15	497
Kyoko Hattori Japan	10	75 0.1×	177 0.4×	60 0.3×	5 0.0×	45 0.4×	25	379
Chris M. Teigland United States	10	113 0.2×	15 0.0×	139 0.7×	22 0.1×	60 0.6×	22	466
Selim Bakan Türkiye	9	175 0.2×	7 0.0×	99 0.5×	42 0.2×	63 0.6×	32	384

Countries citing papers authored by Michael E. Merhige

Since Specialization

Citations

This map shows the geographic impact of Michael E. Merhige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Merhige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Merhige more than expected).

Fields of papers citing papers by Michael E. Merhige

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Merhige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Merhige. The network helps show where Michael E. Merhige may publish in the future.

Co-authorship network of co-authors of Michael E. Merhige

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Merhige. A scholar is included among the top collaborators of Michael E. Merhige based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Merhige. Michael E. Merhige is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yam, Yeung, Vinay Kansal, Sharmila Dorbala, et al.. (2017). Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging. 45(4). 538–548. 7 indexed citations

Kelkar, Anita A., Leslee J. Shaw, Pratik B. Sandesara, et al.. (2015). PROGNOSTIC SIGNIFICANCE OF RESTING BLOOD PRESSURE AND BLOOD PRESSURE RESPONSE DURING VASODILATOR STRESS RB-82 POSITRON EMISSION TOMOGRAPHY MYOCARDIAL PERFUSION IMAGING. Journal of the American College of Cardiology. 65(10). A1147–A1147. 1 indexed citations

Skali, Hicham, Marcelo F. Di Carli, Ron Blankstein, et al.. (2014). Abstract 18193: Stress Myocardial Perfusion Positron Emission Tomography Provides Incremental Risk Prediction in Subjects With and Without Diabetes. Circulation. 130. 1 indexed citations

Bellam, Naveen, Emir Veledar, Sharmila Dorbala, et al.. (2014). Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. Journal of Nuclear Cardiology. 21(2). 233–244. 20 indexed citations

Chow, Benjamin J.W., Sharmila Dorbala, Marcelo F. Di Carli, et al.. (2014). Prognostic Value of PET Myocardial Perfusion Imaging in Obese Patients. JACC. Cardiovascular imaging. 7(3). 278–287. 49 indexed citations

Williams, Brent A. & Michael E. Merhige. (2014). Comparing Changes in Severe Versus Mild Perfusion Defect Size in Patients Who Underwent Serial Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging. The American Journal of Cardiology. 114(10). 1512–1517. 1 indexed citations

Kay, Jenna, Sharmila Dorbala, Abhinav Goyal, et al.. (2013). Influence of Sex on Risk Stratification With Stress Myocardial Perfusion Rb-82 Positron Emission Tomography. Journal of the American College of Cardiology. 62(20). 1866–1876. 53 indexed citations

Williams, Brent A. & Michael E. Merhige. (2013). Association between neutrophil–lymphocyte ratio and impaired myocardial perfusion in patients with known or suspected coronary disease. Heart & Lung. 42(6). 436–441. 25 indexed citations

Dorbala, Sharmila, Marcelo F. Di Carli, Rob Beanlands, et al.. (2012). Prognostic Value of Stress Myocardial Perfusion Positron Emission Tomography. Journal of the American College of Cardiology. 61(2). 176–184. 143 indexed citations

10.

Williams, Brent A. & Michael E. Merhige. (2012). The prognostic association between resting heart rate and cardiac death—Myocardial perfusion defects as a potential mechanism. Atherosclerosis. 221(2). 445–450. 8 indexed citations

11.

Leonard, Deborah A., et al.. (2011). Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease. Coronary Artery Disease. 22(7). 491–496. 17 indexed citations

12.

Merhige, Michael E. & Brent A. Williams. (2010). Abstract 21379: The Prognostic Value of Longitudinal Change in Myocardial Perfusion Defect Size as Measured by Rubidium-82 Positron Emission Tomography. Circulation. 122.

13.

Merhige, Michael E., et al.. (2007). Impact of Myocardial Perfusion Imaging with PET and 82Rb on Downstream Invasive Procedure Utilization, Costs, and Outcomes in Coronary Disease Management. Journal of Nuclear Medicine. 48(7). 1069–1076. 87 indexed citations

14.

Merhige, Michael E., et al.. (2004). 804-2 Efficacy of lipid lowering therapy in inducing arrest or reversal of coronary disease as assessed with positron emission tomography. Journal of the American College of Cardiology. 43(5). A332–A332. 1 indexed citations

15.

Merhige, Michael E., et al.. (2004). Efficacy of lipid lowering therapy in inducing arrest or reversal of coronary disease: Serial assessment of perfusion with PET predicts clinical outcome. Journal of Nuclear Cardiology. 11(4). S32–S32. 2 indexed citations

16.

Merhige, Michael E., et al.. (1998). PET myocardial perfusion imaging cuts the cost of coronary disease management by eliminating unnecessary invasive diagnostic and therapeutic procedures. Journal of the American College of Cardiology. 31. 485–485. 2 indexed citations

17.

Merhige, Michael E., Dahlia Garza, R. W. Rowe, et al.. (1991). Quantitation of the critically ischemic zone at risk during acute coronary occlusion using PET.. PubMed. 32(8). 1581–6. 3 indexed citations

18.

Smalling, Richard W., Richard R. Schumacher, Douglas C. Morris, et al.. (1990). Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: Results of a multicenter randomized trial of two dosage regimens. Journal of the American College of Cardiology. 15(5). 915–921. 58 indexed citations

19.

Merhige, Michael E. & Dahlia Garza. (1989). Positron Emission Tomography of the Heart: Mapping Flow and Metabolism In Vivo. Mayo Clinic Proceedings. 64(6). 716–719. 2 indexed citations

20.

Demer, Linda L., K. Lance Gould, Richard A. Goldstein, et al.. (1989). Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients.. Circulation. 79(4). 825–835. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact